 | • レポートコード：QFJ1-5759 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、グラニセトロンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経皮システム、注射、経口）、用途別市場規模（化学療法、術後）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・グラニセトロンの市場動向 ・企業の競争状況、市場シェア ・グラニセトロンの種類別市場規模と予測2016-2027（経皮システム、注射、経口） ・グラニセトロンの用途別市場規模と予測2016-2027（化学療法、術後） ・グラニセトロンの北米市場規模2016-2027（アメリカ、カナダ） ・グラニセトロンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・グラニセトロンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・グラニセトロンの中南米市場規模2016-2027（メキシコ、ブラジル） ・グラニセトロンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Kyowa Kirin、Heron Therapeutics、Fresenius Kabi、Hikma Pharmaceuticals、Teva、Cipla、Sandoz、Wockhardt、Mylan、APOTEX、Dr.Reddy's、Bluepharma、Natco Pharma、Akorn、Taro Pharmaceutical、Aurobindo） ・結論 |
Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy and Radiotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata.
Market Analysis and Insights: Global Granisetron Market
The global Granisetron market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Granisetron market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Granisetron market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Granisetron market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Granisetron market.
Global Granisetron Scope and Market Size
Granisetron market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Granisetron market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Transdermal system
Injection
Oral
Segment by Application
Chemotherapy
Post operative
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Kyowa Kirin
Heron Therapeutics
Fresenius Kabi
Hikma Pharmaceuticals
Teva
Cipla
Sandoz
Wockhardt
Mylan
APOTEX
Dr.Reddy’s
Bluepharma
Natco Pharma
Akorn
Taro Pharmaceutical
Aurobindo
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Granisetron Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Transdermal system
1.2.3 Injection
1.2.4 Oral
1.3 Market by Application
1.3.1 Global Granisetron Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chemotherapy
1.3.3 Post operative
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Granisetron Market Perspective (2016-2027)
2.2 Granisetron Growth Trends by Regions
2.2.1 Granisetron Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Granisetron Historic Market Share by Regions (2016-2021)
2.2.3 Granisetron Forecasted Market Size by Regions (2022-2027)
2.3 Granisetron Industry Dynamic
2.3.1 Granisetron Market Trends
2.3.2 Granisetron Market Drivers
2.3.3 Granisetron Market Challenges
2.3.4 Granisetron Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Granisetron Players by Revenue
3.1.1 Global Top Granisetron Players by Revenue (2016-2021)
3.1.2 Global Granisetron Revenue Market Share by Players (2016-2021)
3.2 Global Granisetron Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Granisetron Revenue
3.4 Global Granisetron Market Concentration Ratio
3.4.1 Global Granisetron Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Granisetron Revenue in 2020
3.5 Granisetron Key Players Head office and Area Served
3.6 Key Players Granisetron Product Solution and Service
3.7 Date of Enter into Granisetron Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Granisetron Breakdown Data by Type
4.1 Global Granisetron Historic Market Size by Type (2016-2021)
4.2 Global Granisetron Forecasted Market Size by Type (2022-2027)
5 Granisetron Breakdown Data by Application
5.1 Global Granisetron Historic Market Size by Application (2016-2021)
5.2 Global Granisetron Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Granisetron Market Size (2016-2027)
6.2 North America Granisetron Market Size by Type
6.2.1 North America Granisetron Market Size by Type (2016-2021)
6.2.2 North America Granisetron Market Size by Type (2022-2027)
6.2.3 North America Granisetron Market Size by Type (2016-2027)
6.3 North America Granisetron Market Size by Application
6.3.1 North America Granisetron Market Size by Application (2016-2021)
6.3.2 North America Granisetron Market Size by Application (2022-2027)
6.3.3 North America Granisetron Market Size by Application (2016-2027)
6.4 North America Granisetron Market Size by Country
6.4.1 North America Granisetron Market Size by Country (2016-2021)
6.4.2 North America Granisetron Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Granisetron Market Size (2016-2027)
7.2 Europe Granisetron Market Size by Type
7.2.1 Europe Granisetron Market Size by Type (2016-2021)
7.2.2 Europe Granisetron Market Size by Type (2022-2027)
7.2.3 Europe Granisetron Market Size by Type (2016-2027)
7.3 Europe Granisetron Market Size by Application
7.3.1 Europe Granisetron Market Size by Application (2016-2021)
7.3.2 Europe Granisetron Market Size by Application (2022-2027)
7.3.3 Europe Granisetron Market Size by Application (2016-2027)
7.4 Europe Granisetron Market Size by Country
7.4.1 Europe Granisetron Market Size by Country (2016-2021)
7.4.2 Europe Granisetron Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Granisetron Market Size (2016-2027)
8.2 Asia-Pacific Granisetron Market Size by Type
8.2.1 Asia-Pacific Granisetron Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Granisetron Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Granisetron Market Size by Type (2016-2027)
8.3 Asia-Pacific Granisetron Market Size by Application
8.3.1 Asia-Pacific Granisetron Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Granisetron Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Granisetron Market Size by Application (2016-2027)
8.4 Asia-Pacific Granisetron Market Size by Region
8.4.1 Asia-Pacific Granisetron Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Granisetron Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Granisetron Market Size (2016-2027)
9.2 Latin America Granisetron Market Size by Type
9.2.1 Latin America Granisetron Market Size by Type (2016-2021)
9.2.2 Latin America Granisetron Market Size by Type (2022-2027)
9.2.3 Latin America Granisetron Market Size by Type (2016-2027)
9.3 Latin America Granisetron Market Size by Application
9.3.1 Latin America Granisetron Market Size by Application (2016-2021)
9.3.2 Latin America Granisetron Market Size by Application (2022-2027)
9.3.3 Latin America Granisetron Market Size by Application (2016-2027)
9.4 Latin America Granisetron Market Size by Country
9.4.1 Latin America Granisetron Market Size by Country (2016-2021)
9.4.2 Latin America Granisetron Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Granisetron Market Size (2016-2027)
10.2 Middle East & Africa Granisetron Market Size by Type
10.2.1 Middle East & Africa Granisetron Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Granisetron Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Granisetron Market Size by Type (2016-2027)
10.3 Middle East & Africa Granisetron Market Size by Application
10.3.1 Middle East & Africa Granisetron Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Granisetron Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Granisetron Market Size by Application (2016-2027)
10.4 Middle East & Africa Granisetron Market Size by Country
10.4.1 Middle East & Africa Granisetron Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Granisetron Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Kyowa Kirin
11.1.1 Kyowa Kirin Company Details
11.1.2 Kyowa Kirin Business Overview
11.1.3 Kyowa Kirin Granisetron Introduction
11.1.4 Kyowa Kirin Revenue in Granisetron Business (2016-2021)
11.1.5 Kyowa Kirin Recent Development
11.2 Heron Therapeutics
11.2.1 Heron Therapeutics Company Details
11.2.2 Heron Therapeutics Business Overview
11.2.3 Heron Therapeutics Granisetron Introduction
11.2.4 Heron Therapeutics Revenue in Granisetron Business (2016-2021)
11.2.5 Heron Therapeutics Recent Development
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Details
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Granisetron Introduction
11.3.4 Fresenius Kabi Revenue in Granisetron Business (2016-2021)
11.3.5 Fresenius Kabi Recent Development
11.4 Hikma Pharmaceuticals
11.4.1 Hikma Pharmaceuticals Company Details
11.4.2 Hikma Pharmaceuticals Business Overview
11.4.3 Hikma Pharmaceuticals Granisetron Introduction
11.4.4 Hikma Pharmaceuticals Revenue in Granisetron Business (2016-2021)
11.4.5 Hikma Pharmaceuticals Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Granisetron Introduction
11.5.4 Teva Revenue in Granisetron Business (2016-2021)
11.5.5 Teva Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Granisetron Introduction
11.6.4 Cipla Revenue in Granisetron Business (2016-2021)
11.6.5 Cipla Recent Development
11.7 Sandoz
11.7.1 Sandoz Company Details
11.7.2 Sandoz Business Overview
11.7.3 Sandoz Granisetron Introduction
11.7.4 Sandoz Revenue in Granisetron Business (2016-2021)
11.7.5 Sandoz Recent Development
11.8 Wockhardt
11.8.1 Wockhardt Company Details
11.8.2 Wockhardt Business Overview
11.8.3 Wockhardt Granisetron Introduction
11.8.4 Wockhardt Revenue in Granisetron Business (2016-2021)
11.8.5 Wockhardt Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Granisetron Introduction
11.9.4 Mylan Revenue in Granisetron Business (2016-2021)
11.9.5 Mylan Recent Development
11.10 APOTEX
11.10.1 APOTEX Company Details
11.10.2 APOTEX Business Overview
11.10.3 APOTEX Granisetron Introduction
11.10.4 APOTEX Revenue in Granisetron Business (2016-2021)
11.10.5 APOTEX Recent Development
11.11 Dr.Reddy’s
11.11.1 Dr.Reddy’s Company Details
11.11.2 Dr.Reddy’s Business Overview
11.11.3 Dr.Reddy’s Granisetron Introduction
11.11.4 Dr.Reddy’s Revenue in Granisetron Business (2016-2021)
11.11.5 Dr.Reddy’s Recent Development
11.12 Bluepharma
11.12.1 Bluepharma Company Details
11.12.2 Bluepharma Business Overview
11.12.3 Bluepharma Granisetron Introduction
11.12.4 Bluepharma Revenue in Granisetron Business (2016-2021)
11.12.5 Bluepharma Recent Development
11.13 Natco Pharma
11.13.1 Natco Pharma Company Details
11.13.2 Natco Pharma Business Overview
11.13.3 Natco Pharma Granisetron Introduction
11.13.4 Natco Pharma Revenue in Granisetron Business (2016-2021)
11.13.5 Natco Pharma Recent Development
11.14 Akorn
11.14.1 Akorn Company Details
11.14.2 Akorn Business Overview
11.14.3 Akorn Granisetron Introduction
11.14.4 Akorn Revenue in Granisetron Business (2016-2021)
11.14.5 Akorn Recent Development
11.15 Taro Pharmaceutical
11.15.1 Taro Pharmaceutical Company Details
11.15.2 Taro Pharmaceutical Business Overview
11.15.3 Taro Pharmaceutical Granisetron Introduction
11.15.4 Taro Pharmaceutical Revenue in Granisetron Business (2016-2021)
11.15.5 Taro Pharmaceutical Recent Development
11.16 Aurobindo
11.16.1 Aurobindo Company Details
11.16.2 Aurobindo Business Overview
11.16.3 Aurobindo Granisetron Introduction
11.16.4 Aurobindo Revenue in Granisetron Business (2016-2021)
11.16.5 Aurobindo Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Granisetron Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Transdermal system
Table 3. Key Players of Injection
Table 4. Key Players of Oral
Table 5. Global Granisetron Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Granisetron Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Granisetron Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Granisetron Market Share by Regions (2016-2021)
Table 9. Global Granisetron Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Granisetron Market Share by Regions (2022-2027)
Table 11. Granisetron Market Trends
Table 12. Granisetron Market Drivers
Table 13. Granisetron Market Challenges
Table 14. Granisetron Market Restraints
Table 15. Global Granisetron Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Granisetron Market Share by Players (2016-2021)
Table 17. Global Top Granisetron Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granisetron as of 2020)
Table 18. Ranking of Global Top Granisetron Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Granisetron Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Granisetron Product Solution and Service
Table 22. Date of Enter into Granisetron Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Granisetron Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Granisetron Revenue Market Share by Type (2016-2021)
Table 26. Global Granisetron Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Granisetron Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Granisetron Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Granisetron Revenue Market Share by Application (2016-2021)
Table 30. Global Granisetron Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Granisetron Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Granisetron Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Granisetron Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Granisetron Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Granisetron Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Granisetron Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Granisetron Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Granisetron Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Granisetron Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Granisetron Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Granisetron Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Granisetron Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Granisetron Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Granisetron Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Granisetron Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Granisetron Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Granisetron Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Granisetron Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Granisetron Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Granisetron Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Granisetron Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Granisetron Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Granisetron Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Granisetron Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Granisetron Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Granisetron Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Granisetron Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Granisetron Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Granisetron Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Granisetron Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Granisetron Market Size by Country (2022-2027) & (US$ Million)
Table 62. Kyowa Kirin Company Details
Table 63. Kyowa Kirin Business Overview
Table 64. Kyowa Kirin Granisetron Product
Table 65. Kyowa Kirin Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 66. Kyowa Kirin Recent Development
Table 67. Heron Therapeutics Company Details
Table 68. Heron Therapeutics Business Overview
Table 69. Heron Therapeutics Granisetron Product
Table 70. Heron Therapeutics Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 71. Heron Therapeutics Recent Development
Table 72. Fresenius Kabi Company Details
Table 73. Fresenius Kabi Business Overview
Table 74. Fresenius Kabi Granisetron Product
Table 75. Fresenius Kabi Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 76. Fresenius Kabi Recent Development
Table 77. Hikma Pharmaceuticals Company Details
Table 78. Hikma Pharmaceuticals Business Overview
Table 79. Hikma Pharmaceuticals Granisetron Product
Table 80. Hikma Pharmaceuticals Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 81. Hikma Pharmaceuticals Recent Development
Table 82. Teva Company Details
Table 83. Teva Business Overview
Table 84. Teva Granisetron Product
Table 85. Teva Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 86. Teva Recent Development
Table 87. Cipla Company Details
Table 88. Cipla Business Overview
Table 89. Cipla Granisetron Product
Table 90. Cipla Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 91. Cipla Recent Development
Table 92. Sandoz Company Details
Table 93. Sandoz Business Overview
Table 94. Sandoz Granisetron Product
Table 95. Sandoz Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 96. Sandoz Recent Development
Table 97. Wockhardt Company Details
Table 98. Wockhardt Business Overview
Table 99. Wockhardt Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 100. Wockhardt Recent Development
Table 101. Mylan Company Details
Table 102. Mylan Business Overview
Table 103. Mylan Granisetron Product
Table 104. Mylan Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 105. Mylan Recent Development
Table 106. APOTEX Company Details
Table 107. APOTEX Business Overview
Table 108. APOTEX Granisetron Product
Table 109. APOTEX Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 110. APOTEX Recent Development
Table 111. Dr.Reddy's Company Details
Table 112. Dr.Reddy's Business Overview
Table 113. Dr.Reddy's Granisetron Product
Table 114. Dr.Reddy's Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 115. Dr.Reddy's Recent Development
Table 116. Bluepharma Company Details
Table 117. Bluepharma Business Overview
Table 118. Bluepharma Granisetron Product
Table 119. Bluepharma Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 120. Bluepharma Recent Development
Table 121. Natco Pharma Company Details
Table 122. Natco Pharma Business Overview
Table 123. Natco Pharma Granisetron Product
Table 124. Natco Pharma Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 125. Natco Pharma Recent Development
Table 126. Akorn Company Details
Table 127. Akorn Business Overview
Table 128. Akorn Granisetron Product
Table 129. Akorn Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 130. Akorn Recent Development
Table 131. Taro Pharmaceutical Company Details
Table 132. Taro Pharmaceutical Business Overview
Table 133. Taro Pharmaceutical Granisetron Product
Table 134. Taro Pharmaceutical Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 135. Taro Pharmaceutical Recent Development
Table 136. Aurobindo Company Details
Table 137. Aurobindo Business Overview
Table 138. Aurobindo Granisetron Product
Table 139. Aurobindo Revenue in Granisetron Business (2016-2021) & (US$ Million)
Table 140. Aurobindo Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Granisetron Market Share by Type: 2020 VS 2027
Figure 2. Transdermal system Features
Figure 3. Injection Features
Figure 4. Oral Features
Figure 5. Global Granisetron Market Share by Application: 2020 VS 2027
Figure 6. Chemotherapy Case Studies
Figure 7. Post operative Case Studies
Figure 8. Granisetron Report Years Considered
Figure 9. Global Granisetron Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Granisetron Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Granisetron Market Share by Regions: 2020 VS 2027
Figure 12. Global Granisetron Market Share by Regions (2022-2027)
Figure 13. Global Granisetron Market Share by Players in 2020
Figure 14. Global Top Granisetron Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Granisetron as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Granisetron Revenue in 2020
Figure 16. Global Granisetron Revenue Market Share by Type (2016-2021)
Figure 17. Global Granisetron Revenue Market Share by Type (2022-2027)
Figure 18. North America Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Granisetron Market Share by Type (2016-2027)
Figure 20. North America Granisetron Market Share by Application (2016-2027)
Figure 21. North America Granisetron Market Share by Country (2016-2027)
Figure 22. United States Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Granisetron Market Share by Type (2016-2027)
Figure 26. Europe Granisetron Market Share by Application (2016-2027)
Figure 27. Europe Granisetron Market Share by Country (2016-2027)
Figure 28. Germany Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Granisetron Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Granisetron Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Granisetron Market Share by Region (2016-2027)
Figure 38. China Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Granisetron Market Share by Type (2016-2027)
Figure 46. Latin America Granisetron Market Share by Application (2016-2027)
Figure 47. Latin America Granisetron Market Share by Country (2016-2027)
Figure 48. Mexico Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Granisetron Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Granisetron Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Granisetron Market Share by Country (2016-2027)
Figure 54. Turkey Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Granisetron Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Kyowa Kirin Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 58. Heron Therapeutics Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 59. Fresenius Kabi Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 60. Hikma Pharmaceuticals Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 61. Teva Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 62. Cipla Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 63. Sandoz Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 64. Wockhardt Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 66. APOTEX Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 67. Dr.Reddy's Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 68. Bluepharma Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 69. Natco Pharma Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 70. Akorn Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 71. Taro Pharmaceutical Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 72. Aurobindo Revenue Growth Rate in Granisetron Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の経皮パッチ薬物送達システム市場規模・現状・予測（2021年-2027年） Transdermal patches drug delivery system are a method of delivering drugs directly through the skin into the bloodstream.It mainly has polymer matrix, drug, penetration accelerator and adhesive layer.Patches can provide controlled, continuous administration of drugs that are easy to eat with minimal…- 世界の末梢神経損傷手術市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Peripheral Nerves Injury Operative Market The global Peripheral Nerves Injury Operative market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high …
- 世界の化学医薬品市場規模・現状・予測（2021年-2027年） Chemotherapy is the use of any drug to treat any disease. But to most people, the wordchemotherapy means drugs used for cancer treatment. Market Analysis and Insights: Global Chemotherapy Drug Market The global Chemotherapy Drug market size is projected to reach US$ XX million by 2027, from US$ XX m…
- 世界の非侵襲性脊椎治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-Operative Spine Care Market The global Non-Operative Spine Care market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the …
- 世界の化学療法誘発性血小板減少症治療薬市場規模・現状・予測（2021年-2027年） Chemotherapy is the cancer treatment given to patients with different forms of the cancer. Various drugs such as alkylating agents, antimetabolites, targeted therapy, immunotherapy drugs, etc. are used for the cancer treatment. These chemotherapy agents acts against the cancerous as well as normal c…